3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Diseases
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Bevacizumab
5
Leucovorin
4
Irinotecan
4
Fluorouracil
4
Oxaliplatin
3
Capecitabine
3
Drug Therapy
2
trifluridine tipiracil drug combination
1
romiplostim
1
napabucasin
1
entecavir
1
encorafenib
1
durvalumab
1
apatinib
1
abelacimab
1
Sunitinib
1
Specimen Handling
1
Sodium Chloride
1
S-1 plus cisplatin
1
Radiosurgery
1
Palonosetron
1
Oviposition
1
Nutrition Assessment
1
Nucleotides
1
Methylphenidate
1
Memantine
1
Melatonin
1
Magnetic Resonance Spectroscopy
1
MAA868
1
Levoleucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Gastrointestinal Neoplasms
×
Oviposition
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled